Suspected oncologic adverse reactions associated with interleukin‐23 inhibitors in EudraVigilance: Comparative study and gender distribution

Psoriasis is a chronic inflammatory skin disease characterized by plaque formation. Interleukin (IL)‐23 is upregulated in psoriatic lesions and is thought to be a major regulator of the Th17 pathway in psoriasis pathogenesis. Three monoclonal antibodies targeting the IL‐23p19 subunit, guselkumab, ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Calapai, Fabrizio, Mannucci, Carmen, Cardia, Luigi, Currò, Mariaconcetta, Calapai, Gioacchino, Esposito, Emanuela, Ammendolia, Ilaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448453/
https://www.ncbi.nlm.nih.gov/pubmed/37615258
http://dx.doi.org/10.1002/prp2.1130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448453/
https://www.ncbi.nlm.nih.gov/pubmed/37615258
http://dx.doi.org/10.1002/prp2.1130

Ejemplares similares